Bhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, H., Baden, L., Chi-Chung Cheng, V., Edwards, K. M., Gandhi, R., Gallagher, J., Muller, W. J., O’Horo, J. C., Shoham, S., Murad, M. S., Mustafa, R. A., Sultan, S., Falck-Ytter, F., (2020, December 2). Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Infectious Diseases Society of America Guidelines. idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/
Center for Disease Control and Prevention (2020, December 22) Symptoms of Coronavirus. cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
Ding, L. Wang, L. Ma, W. He, H. (2020) Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: A multi-center prospective cohort study. Crit Care. 24(28).
Horby PW et al. Effect of Dexamethasone in Hospitalized Patients With COVID-19 – Preliminary Report. N Engl J Med. Jul 17 2020. DOI: 10.1056/NEJMoa2021436
World Health Organization (2020, September 2). Corticosteroids for COVID-19. Living Guidance. who.int/publications/i/item/WHO-2019-nCoV-Corticosteroids-2020.1